Interleukin 6 and haemostasis.
Kerr
R
R
Department of Haematology, The Royal Infirmary of Edinburgh, Edinburgh, UK. ron.kerr@ed.ac.uk
Stirling
D
D
Ludlam
C A
CA
D001161:Arteriosclerosis / Q000628:therapy; D001779:Blood Coagulation Factors / Q000378:metabolism*; D001792:Blood Platelets / Q000502:physiology; D004730:Endothelium, Vascular / Q000378:metabolism; D005169:Factor VIII / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006487:Hemostasis / Q000502:physiology*; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D015850:Interleukin-6 / Q000502:physiology* / Q000627:therapeutic use; D007962:Leukocytes / Q000378:metabolism; D008954:Models, Biological; D019947:Receptors, Interleukin-6 / Q000378:metabolism; D013925:Thromboplastin / Q000378:metabolism; D013927:Thrombosis / Q000097:blood*; D020246:Venous Thrombosis / Q000097:blood / Q000628:therapy; D014841:von Willebrand Factor / Q000378:metabolism
D001779:Blood Coagulation Factors; D015850:Interleukin-6; D019947:Receptors, Interleukin-6; D014841:von Willebrand Factor; D005169:Factor VIII; D005340:Fibrinogen; D013925:Thromboplastin